Trial intelligence / Profile preview

ED50 of Dexmedetomidine in Lidocaine IVRA

NCT05342870Completed

Sponsor
American University of Beirut Medical Center
Start
Aug 2012
Primary completion
Aug 2013
Modality
Small Molecules
01

Overview

Single-blind, single-arm trial of dexmedetomidine, sponsored by American University of Beirut Medical Center. Primary endpoint: Median effective dose of dexmedetomidine. Started Aug 2012; status: completed.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on NCT05342870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05342870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call